Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adolescents: Real World, Open Label, Quality of Life Study

NCT03703791 is registered in ClinicalTrials.gov with Aimmune Therapeutics, Inc. as lead sponsor.

NCT NCT03703791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03703791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adolescents: Real World, Open Label, Quality of Life Study
Lead sponsor
Aimmune Therapeutics, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
October 24, 2018
Completion date
November 23, 2018
Enrollment
1 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

peanut allergy